Sampat Ingale

Sampat Ingale is a seasoned professional in peptide and protein chemistry, currently serving as Senior Director at Biohaven since September 2023. Previously, Ingale held the title of Director of Peptide Chemistry at Flagship Pioneering and Director of Chemistry, where strategies for lipid nanoparticle decoration were developed. During a significant tenure at Merck, Ingale progressed from Associate Principal Scientist to Principal Scientist, contributing to advancements in antibody-drug conjugate design and synthetic peptide evaluation. Additional experience includes roles at Novo Nordisk focusing on obesity-related peptides, Sorrento Therapeutics with antibody oligonucleotide conjugation, and leadership positions at Nycomed Pharma. Ingale's educational background includes a PhD in Organic Chemistry from The University of Georgia, alongside degrees from the University Institute of Chemical Technology and the University of Mumbai.